Chronic bronchitis in rural and industrial areas.
More details
Hide details
Lung Function Laboratory, Department of Physiology, Medical School, University of Thessaly, Larissa, Greece
Ann Agric Environ Med. 2000;7(1):29–31
The purpose of the study was the determination of prevalence of chronic bronchitis in people older than 55 years in rural and industrial areas. 569 people over 55 years old living in central Greece were studied. A protocol was completed for each patient that included smoking habits, job, age, weight, drugs used for respiratory system and symptoms. A chest radiograph was taken for each patient. Each patient was submitted to three trials of dynamic spirometry. The best results were used for the study. The patients who complained of expectoration for three months for two continuous years and had obstructive pattern of lung function were diagnosed with chronic bronchitis. 9.6% of the subjects in rural area and 17.1% in industrial area were diagnosed with chronic bronchitis. Half the COPD patients never visited a doctor for this specific problem and were diagnosed for the first time. One out of three examined people had abnormal lung function. Consequently, more than one out of ten people older than 55 years have chronic bronchitis. Industrial exposure seems to double the risk for chronic bronchitis.
American Thoracic Society: Standards for the diagnosis and care of patients with COPD. Am J Respir Crit Care Med 1995, 152, S77-S120.
ATS STATEMENT: Lung fuction testing: Selection of reference values and interpretative strategies. Am Rev Respir Dis 1991, 144, 1202-1218.
Bakke PS, Baste V, Hanoa R, Gulvik A: Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1988, 46, 863-870.
Burge PS: Occupation and COPD. Eur Respir J 1994, 7, 1032-1034.
Burrows B: Epidemiologic evidence for different types of chronic airfow obstruction. Am Rev Respir Dis 1991, 140, 225-252.
Burrows B: Predictors of loss of lung fuction and mortality in obstructive lung diseases. Eur Respir Rev 1991, 1, 340-345.
European Pulmonary Society (ERS) Siafakas NM, Vermeire P: Optimum evaluation of severity and therapy of Chronic Obstructive Pulmonary Disease. Eur Respir J 1995, 8, 1398-1420.
Ferguson GT, Cherniack RM: Management of COPD. N Engl J Med 1993, 328, 1017-1022.
Georgopoulos D, Authonisen NR: Symptoms and signs of COPD. In: Cherniack N (Ed): Chronic Obstructive Pulmonary Disease. Saunders, NY 1990, 357-363.
Gourgoulianis KI, Lavdas E, Mizios P: Prescription of bronchodilator drugs by primary health care physicians in asthma. Respiration 1994, 61, 204-206.
Hendrick DJ: OccupatioQ DQG & 3' Thorax 1996, 51, 947-.
Jeffery PK: Chronic obstructive pulmonary disease and cigarette smoke-induced epithelial damage. Eur Respir Rev 1992, 2, 136-143.
Sherril DL, Lebiwitz MD, Burrows B: Epidemiology of COPD. Clin Chest Med 1990, 11, 375-388.